{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:11:02Z","timestamp":1777529462839,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY316"],"award-info":[{"award-number":["2022KY316"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.mrfmmm.2024.111869","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:02:29Z","timestamp":1718737349000},"page":"111869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MicroRNA-138 promotes the progression of multiple myeloma through targeting paired PAX5"],"prefix":"10.1016","volume":"829","author":[{"given":"Xiao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaihong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qitian","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mrfmmm.2024.111869_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cas.13840","article-title":"Dual inhibition of enhancer of zeste homolog 1\/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma[J]","volume":"110","author":"Nakagawa","year":"2019","journal-title":"Cancer Sci."},{"issue":"7123","key":"10.1016\/j.mrfmmm.2024.111869_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J]","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"issue":"6859","key":"10.1016\/j.mrfmmm.2024.111869_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells[J]","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"27-28","key":"10.1016\/j.mrfmmm.2024.111869_bib4","first-page":"470","article-title":"The diagnosis and treatment of multiple myeloma[J]","volume":"113","author":"Gerecke","year":"2016","journal-title":"Dtsch Arztebl Int."},{"issue":"17","key":"10.1016\/j.mrfmmm.2024.111869_bib5","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2007.15.8428","article-title":"Multiple myeloma cancer stem cells[J]","volume":"26","author":"Huff","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.mrfmmm.2024.111869_bib6","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma[J]","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.mrfmmm.2024.111869_bib7","doi-asserted-by":"crossref","first-page":"35466","DOI":"10.18632\/oncotarget.8154","article-title":"Multiple myeloma cancer stem cells[J]","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib8","doi-asserted-by":"crossref","unstructured":"S. Alonso, D. Hernandez, Y.T. Chang, C.D. Gocke, GJJoCI Ghiaur. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance[J]. 2016, 126(12): 4460-4468.","DOI":"10.1172\/JCI88152"},{"issue":"9","key":"10.1016\/j.mrfmmm.2024.111869_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1182\/blood-2017-07-797050","article-title":"Syndecan-1 promotes Wnt\/beta-catenin signaling in multiple myeloma by presenting Wnts and R-spondins[J].","volume":"131","author":"Ren","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib10","doi-asserted-by":"crossref","unstructured":"M. Colombo, S. Galletti, S. Garavelli, N. Platonova, A. Paoli, A. Basile, et al. Notch signaling deregulation in multiple myeloma: A rational molecular target[J]. 2015.","DOI":"10.18632\/oncotarget.5025"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib11","doi-asserted-by":"crossref","unstructured":"Wu, Xu, Niu, Huang, ZJIJoM Medicine. shRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib[J]. 2014, 34(2): 616-623.","DOI":"10.3892\/ijmm.2014.1798"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib12","doi-asserted-by":"crossref","unstructured":"A.M. Mohr, J.L.J.Si.L.D. Mott. Overview of MicroRNA Biology[J]. 2015, 35(01): 003-011.","DOI":"10.1055\/s-0034-1397344"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib13","doi-asserted-by":"crossref","unstructured":"T. Tian, J. Wang, X.J.O. Zhou, B Chemistry. A review: microRNA detection methods[J]. 2015, 13(8): 2226-2238.","DOI":"10.1039\/C4OB02104E"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib14","doi-asserted-by":"crossref","unstructured":"N. Rastgoo, M. Pourabdollah, J. Abdi, D. Reece, H.J.L. Chang. Dysregulation of EZH2\/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS[J]. 2018.","DOI":"10.1038\/s41375-018-0140-y"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib15","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2831","article-title":"Identification of four potential predicting miRNA biomarkers for multiple myeloma from published datasets[J]","volume":"5","author":"Xiang","year":"2017","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.mrfmmm.2024.111869_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrc1778","article-title":"MR Eccles. A PANorama of PAX genes in cancer and development[J]","volume":"6","author":"Robson","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.mrfmmm.2024.111869_bib17","first-page":"1251","article-title":"Bergeron. A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma[J]","volume":"93","author":"Xu","year":"2014","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.mrfmmm.2024.111869_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia[J]","volume":"51","author":"Gu","year":"2019","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.mrfmmm.2024.111869_bib19","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41375-018-0140-y","article-title":"Dysregulation of EZH2\/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS[J]","volume":"32","author":"Rastgoo","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.mrfmmm.2024.111869_bib20","first-page":"10276","article-title":"Reduced serum miR-138 is associated with poor prognosis of head and neck squamous cell carcinoma[J]","volume":"10","author":"Bao","year":"2017","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111869_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oraloncology.2016.02.015","article-title":"Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs[J]","volume":"56","author":"Datta","year":"2016","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111869_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/B978-0-12-407697-6.00009-X","article-title":"Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma[J]","volume":"303","author":"Jin","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.mrfmmm.2024.111869_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1349-7006.2007.00666.x","article-title":"Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines[J]","volume":"99","author":"Mitomo","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mrfmmm.2024.111869_bib24","doi-asserted-by":"crossref","unstructured":"X.W. Ye, H. Yu, Y.K. Jin, X.T. Jing, X.Y.J.C.R.J. Zhang. miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells[J]. 2015, 9(1).","DOI":"10.1111\/crj.12100"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib25","doi-asserted-by":"crossref","unstructured":"Z. Ye, B. Fang, J. Pan, N. Zhang, J. Huang, C. Xie, et al. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1[J]. 2017.","DOI":"10.3892\/or.2017.5619"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib26","doi-asserted-by":"crossref","unstructured":"Z. Huijun. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. %J Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology[J]. 2013, 1(31).","DOI":"10.1159\/000343349"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib27","doi-asserted-by":"crossref","unstructured":"F. Ma, M. Zhang, W. Gong, M. Weng, Z.J.P.O. Quan. MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma[J]. 2015, 10(5): e0126499.","DOI":"10.1371\/journal.pone.0126499"},{"issue":"4","key":"10.1016\/j.mrfmmm.2024.111869_bib28","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3892\/or.2015.4144","article-title":"miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1[J]","volume":"34","author":"Xu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111869_bib29","doi-asserted-by":"crossref","unstructured":"Q. Zhang, Y. He, M. Nie, W.J.E. Cai, T Medicine. Roles of miR-138 and ISG15 in oral squamous cell carcinoma[J]. 2017, 14(3): 2329-2334.","DOI":"10.3892\/etm.2017.4720"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib30","doi-asserted-by":"crossref","unstructured":"M. Manikandan, A.K.D.M. Rao, K.S. Rajkumar, R. Rajaraman, AKJJoOP Munirajan, Medicine. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics[J]. 2015, 44(10): 792-800.","DOI":"10.1111\/jop.12300"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib31","doi-asserted-by":"crossref","unstructured":"H. Yonglong, H. Haitao, S. Wen, Z. Jingge, Z. Shenfu, YJIJoO Dajiang. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR138 and releasing EZH2 in oral squamous cell carcinoma[J]. 2018.","DOI":"10.3892\/ijo.2018.4247"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib32","doi-asserted-by":"crossref","unstructured":"T. Shokichi, M.B. L?Vendorf, P. Jihye, K.Z. Salem, M.R. Reagan, M. Salomon, et al. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche[J]. 2018, 32: 1.","DOI":"10.1038\/s41375-018-0161-6"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib33","doi-asserted-by":"crossref","unstructured":"K. Okuyama, T. Strid, J. Kuruvilla, R. Somasundaram, M.J.P.G. Sigvardsson. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia[J]. 2019, 15(8): e1008280.","DOI":"10.1371\/journal.pgen.1008280"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib34","doi-asserted-by":"crossref","unstructured":"S. Shah, K.A. Schrader, E. Waanders, A.E. Timms, J. Vijai, C. Miething, et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia[J]. 2013, 45(10): 1226-U1179.","DOI":"10.1038\/ng.2754"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib35","doi-asserted-by":"crossref","unstructured":"L. Smeenk, M. Fischer, S. Jurado, M. Jaritz, A. Azaryan, B. Werner, et al. Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia[J]. 2017, 36(6): 718.","DOI":"10.15252\/embj.201695495"},{"key":"10.1016\/j.mrfmmm.2024.111869_bib36","doi-asserted-by":"crossref","unstructured":"N.D. Borson, M.Q. Lacy, P.J.J.B. Wettstein. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma[J]. 2002, 100(13): 4629-4639.","DOI":"10.1182\/blood.V100.13.4629"},{"issue":"3","key":"10.1016\/j.mrfmmm.2024.111869_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12185-010-0691-9","article-title":"Overexpression of PAX5 induces apoptosis in multiple myeloma cells[J]","volume":"92","author":"Proulx","year":"2010","journal-title":"Int.\u00a0J. Hematol."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:39:13Z","timestamp":1777394353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510724000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S0027510724000198"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111869","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-138 promotes the progression of multiple myeloma through targeting paired PAX5","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111869"}}